Top compounds associated with response to TNFRSF19


Feature Type Standardized
Nominal ANOVA
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC 0.087 0.02
mRNA paclitaxel CCLE pan-cancer AAC -0.12 0.02
mRNA DMOG GDSC1000 pan-cancer AAC -0.084 0.02
mRNA CIL70 CTRPv2 pan-cancer AAC 0.12 0.02
mRNA KHS101 CTRPv2 pan-cancer AAC 0.095 0.02
mRNA CP466722 GDSC1000 pan-cancer AAC -0.077 0.02
mRNA SB590885 GDSC1000 pan-cancer AAC 0.082 0.02
mRNA phloretin CTRPv2 pan-cancer AAC 0.086 0.02
mRNA Erlotinib gCSI pan-cancer AAC -0.15 0.02
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.02
Download CSV